Global Nuclear Medicine Market: Overview
Nuclear medicine relates to the application of radioactive substances in the diagnosis and treatment of diseases. Growing prevalence of various diseases, which is resulting in thriving healthcare industry, the demand for accurate and efficient medicine scans is escalating. Nuclear medicine uses a radionuclide for the process of radioactive decay, with radioactive isotopes and radiological imaging devices as key components. Consequently, the global nuclear medicine market is expected to expand at a healthy growth rate during the forecast period of 2015 to 2024.
This report on global nuclear medicine market is a thorough overview of all the factors that are anticipated to impact the growth rate over the course of next few years. Besides the comprehensive regional and product analysis as well as estimating the market size, this report also features an in-depth analysis of the competitive landscape, including the growth strategies adopted by the top companies in the industry. Moreover, the section on company profiles includes the basic views on the prominent players in the nuclear medicine market and their product portfolios. The aim of the report is to provide research data such as current market size, valuation of the segments, and trends that will help the existing and new player to make more informed choices.
The global nuclear medicine market can be segmented on the basis of product, into nuclear medicine equipment, single photon emission computed tomography (SPECT), positron emission tomography (PET), and radiopharmaceuticals, on the basis of application into oncology, cardiology, and neurology, and on the basis of end user into diagnostic centers, hospitals, and research centers. Geographically, the report studies the lucrativeness of the regions of North America, Asia Pacific, Europe, and Rest of the World.
Global Nuclear Medicine Market: Trends and Opportunities
The rising demand for SPECT and PET imaging, growing incidences of cancer and CVDs, and increasing demand for radiopharmaceuticals are some of the key factors driving the global nuclear medicine market. On the other hand, factors such as high cost, shortage of nuclear medicine, and regulatory hurdles are expected to hinder the growth rate during the forecast period. The report also notes some of the trends of the market, including partnerships for development of nuclear medicine, production based on cyclotron, and growing funding for research and development. All these factors have been thoroughly analyzed in the report and their impact has been estimated.
Currently, the product segment of radiopharmaceuticals accounts for most of the demand and is expected to remain dominant over the period of next few years, which can be attributed to growing use of radioactive pharmaceutical drugs as nuclear imaging agents. The increasing use of various medical radioisotopes such as copper-64, iodine-124, and FDG in molecular studies is expected to boost the growth rate in the near future.
Global Nuclear Medicine Market: Regional Outlook
Currently, North America is the most lucrative region of for the players due to robust healthcare infrastructure and high adoptability of new technology. Europe serves the second most demand as a regional market for nuclear medicine, however, Asia Pacific is expected to extend the demand at the most prominent rate during the forecast period. This rising demand is primarily from the emerging economies of India, China, Australia, and Japan, wherein increased investment on healthcare has escalated in the recent times. Moreover, due to the presence of vast population, neurological and cardiovascular diseases as well as cancer cases are growing, which will further increment the demand in Asia Pacific nuclear medicine market.
Companies mentioned in the research report
Some of the prominent companies currently operational in global nuclear medicine market are Cardinal Health Inc., Bayer AG, Lantheus Medical Imaging, Inc., Mallinckrodt plc, GE Healthcare, Bracco Imaging S.p.A, Nordion, Inc., Eczacibasi-Monrol Nuclear Products, Advanced Accelerator Applications S.A., and IBA Molecular Imaging.
Major regions analyzed under this research report are:
- North America
- Asia Pacific
- Rest of the World
This report gives you access to decisive data such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key highlights of this report
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments
Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.